Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017 2018

Details for Mechanism ID: 18304
Country/Region: Zambia
Year: 2017
Main Partner: Right to Care
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $0 Additional Pipeline Funding: $3,371,538

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Strategic Information (HVSI) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTC_TST_DSD By Test Result: Positive 2018 28,914
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 330,949
HTC_TST_DSD Service Delivery Point (Facility) ANC: 10-14, Negative 2018 178
HTC_TST_DSD Service Delivery Point (Facility) ANC: 15-19, Negative 2018 12,198
HTC_TST_DSD Service Delivery Point (Facility) ANC: 15-19, Positive 2018 264
HTC_TST_DSD Service Delivery Point (Facility) ANC: 20-24, Negative 2018 17,732
HTC_TST_DSD Service Delivery Point (Facility) ANC: 20-24, Positive 2018 846
HTC_TST_DSD Service Delivery Point (Facility) ANC: 25-49, Negative 2018 24,705
HTC_TST_DSD Service Delivery Point (Facility) ANC: 25-49, Positive 2018 1,454
HTC_TST_DSD Service Delivery Point (Facility) Index: 1-9, Negative 2018 3,412
HTC_TST_DSD Service Delivery Point (Facility) Index: 1-9, Positive 2018 79
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Female, Negative 2018 1,713
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Female, Positive 2018 29
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Male, Negative 2018 1,693
HTC_TST_DSD Service Delivery Point (Facility) Index: 10-14, Male, Positive 2018 47
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Female, Negative 2018 812
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Female, Positive 2018 22
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Male, Negative 2018 810
HTC_TST_DSD Service Delivery Point (Facility) Index: 15-19, Male, Positive 2018 22
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Female, Negative 2018 778
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Female, Positive 2018 58
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Male, Negative 2018 767
HTC_TST_DSD Service Delivery Point (Facility) Index: 20-24, Male, Positive 2018 78
HTC_TST_DSD Service Delivery Point (Facility) Index: 25-49, Female, Negative 2018 1,188
HTC_TST_DSD Service Delivery Point (Facility) Index: 25-49, Female, Positive 2018 150
HTC_TST_DSD Service Delivery Point (Facility) Index: 25-49, Male, Negative 2018 1,179
HTC_TST_DSD Service Delivery Point (Facility) Index: 25-49, Male, Positive 2018 160
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Female, Negative 2018 296
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Female, Positive 2018 31
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Male, Negative 2018 294
HTC_TST_DSD Service Delivery Point (Facility) Index: 50+, Male, Positive 2018 33
HTC_TST_DSD Service Delivery Point (Facility) Index: <1, Negative 2018 599
HTC_TST_DSD Service Delivery Point (Facility) Index: <1, Positive 2018 9
HTC_TST_DSD Service Delivery Point (Facility) Index: Unknown Age, Female, Negative 2018 1
HTC_TST_DSD Service Delivery Point (Facility) Index: Unknown Age, Male, Negative 2018 2
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 1-9, Negative 2018 5,950
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 1-9, Positive 2018 299
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2018 2,976
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2018 146
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2018 2,972
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2018 144
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2018 2,133
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2018 107
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2018 2,133
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2018 106
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2018 3,946
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2018 539
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2018 2,963
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2018 403
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 25-49, Female, Negative 2018 3,814
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 25-49, Female, Positive 2018 665
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 25-49, Male, Negative 2018 2,859
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 25-49, Male, Positive 2018 502
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2018 949
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2018 163
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2018 944
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2018 163
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: <1, Negative 2018 1,036
HTC_TST_DSD Service Delivery Point (Facility) Inpatient: <1, Positive 2018 54
HTC_TST_DSD Service Delivery Point (Facility) Malnutrition: Negative 2018 348
HTC_TST_DSD Service Delivery Point (Facility) Malnutrition: Positive 2018 15
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 1-9, Negative 2018 415
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 1-9, Positive 2018 12
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2018 195
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2018 7
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2018 194
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2018 6
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2018 4,409
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2018 174
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2018 4,502
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2018 85
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2018 5,488
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2018 599
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2018 5,792
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2018 297
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 25-49, Female, Negative 2018 3,726
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 25-49, Female, Positive 2018 562
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 25-49, Male, Negative 2018 3,770
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 25-49, Male, Positive 2018 518
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2018 585
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2018 84
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2018 592
HTC_TST_DSD Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2018 74
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Negative 2018 4,313
HTC_TST_DSD Service Delivery Point (Facility) Pediatric : <5 Positive 2018 213
HTC_TST_DSD Service Delivery Point (Facility) TB: 1-9, Negative 2018 1
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Female, Negative 2018 60
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Female, Positive 2018 17
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Male, Negative 2018 77
HTC_TST_DSD Service Delivery Point (Facility) TB: 15-19, Male, Positive 2018 19
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Female, Negative 2018 102
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Female, Positive 2018 23
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Male, Negative 2018 24
HTC_TST_DSD Service Delivery Point (Facility) TB: 20-24, Male, Positive 2018 15
HTC_TST_DSD Service Delivery Point (Facility) TB: 25-49, Female, Negative 2018 102
HTC_TST_DSD Service Delivery Point (Facility) TB: 25-49, Female, Positive 2018 97
HTC_TST_DSD Service Delivery Point (Facility) TB: 25-49, Male, Negative 2018 102
HTC_TST_DSD Service Delivery Point (Facility) TB: 25-49, Male, Positive 2018 98
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Female, Negative 2018 61
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Female, Positive 2018 59
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Male, Negative 2018 60
HTC_TST_DSD Service Delivery Point (Facility) TB: 50+, Male, Positive 2018 60
HTC_TST_DSD Service Delivery Point (Facility) VCT: 1-9, Negative 2018 2,775
HTC_TST_DSD Service Delivery Point (Facility) VCT: 1-9, Positive 2018 137
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2018 1,384
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2018 66
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2018 1,383
HTC_TST_DSD Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2018 81
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2018 10,608
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2018 682
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2018 10,871
HTC_TST_DSD Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2018 570
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2018 10,755
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2018 682
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2018 10,869
HTC_TST_DSD Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2018 982
HTC_TST_DSD Service Delivery Point (Facility) VCT: 25-49, Female, Negative 2018 41,695
HTC_TST_DSD Service Delivery Point (Facility) VCT: 25-49, Female, Positive 2018 7,350
HTC_TST_DSD Service Delivery Point (Facility) VCT: 25-49, Male, Negative 2018 42,676
HTC_TST_DSD Service Delivery Point (Facility) VCT: 25-49, Male, Positive 2018 6,378
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Female, Negative 2018 8,334
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Female, Positive 2018 1,470
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Male, Negative 2018 8,434
HTC_TST_DSD Service Delivery Point (Facility) VCT: 50+, Male, Positive 2018 1,274
HTC_TST_DSD Service Delivery Point (Facility) VCT: <1, Negative 2018 487
HTC_TST_DSD Service Delivery Point (Facility) VCT: <1, Positive 2018 16
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 10-14, Negative 2018 2,111
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 10-14, Positive 2018 19
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 15-19, Negative 2018 3,484
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 15-19, Positive 2018 74
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 20-24, Negative 2018 3,454
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 20-24, Positive 2018 109
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 25-49, Negative 2018 4,537
HTC_TST_DSD Service Delivery Point (Facility) VMMC: 25-49, Positive 2018 446
HTC_TST_DSD Service Delivery Point (Facility)Other PITC: <1, Negative 2018 66
HTC_TST_DSD Sum of Test Result disaggregates 2018 28,914
PMTCT_ART_DSD Already on ART at beginning of current pregnancy 2018 1,287
PMTCT_ART_DSD New on ART 2018 2,662
PMTCT_ART_DSD Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 3,949
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 61,936
PMTCT_EID_DSD Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 3,942
PMTCT_EID_DSD Number of infants with a negative virological test result between 2 and 12 months of birth 2018 3,561
PMTCT_EID_DSD Number of infants with a negative virological test result within 2 months of birth 2018 205
PMTCT_EID_DSD Number of infants with a positive virological test result between 2 and 12 months of birth 2018 171
PMTCT_EID_DSD Number of infants with a positive virological test result within 2 months of birth 2018 5
PMTCT_STAT_DSD By Age (Denominator): 10-14 2018 167
PMTCT_STAT_DSD By Age (Denominator): 20-24 2018 20,746
PMTCT_STAT_DSD By Age (Denominator): 25-49 2018 31,570
PMTCT_STAT_DSD By Age (Denominator): <15-19 2018 13,590
PMTCT_STAT_DSD By Age (Numerator): 10-14 2018 195
PMTCT_STAT_DSD By Age (Numerator): 15-19 2018 12,900
PMTCT_STAT_DSD By Age (Numerator): 20-24 2018 19,874
PMTCT_STAT_DSD By Age (Numerator): 25-49 2018 30,021
PMTCT_STAT_DSD By Number of known positives: 15-19 2018 279
PMTCT_STAT_DSD By Number of known positives: 20-24 2018 442
PMTCT_STAT_DSD By Number of known positives: 25-49 2018 644
PMTCT_STAT_DSD By Number of known positives: 50+ 2018 1
PMTCT_STAT_DSD By Number of new negative: 10-14 2018 173
PMTCT_STAT_DSD By Number of new negative: 15-19 2018 11,429
PMTCT_STAT_DSD By Number of new negative: 20-24 2018 17,905
PMTCT_STAT_DSD By Number of new negative: 25-49 2018 27,195
PMTCT_STAT_DSD By Number of new negative: 50+ 2018 669
PMTCT_STAT_DSD By Number of new positives: 10-14 2018 1
PMTCT_STAT_DSD By Number of new positives: 15-19 2018 551
PMTCT_STAT_DSD By Number of new positives: 20-24 2018 861
PMTCT_STAT_DSD By Number of new positives: 25-49 2018 1,282
PMTCT_STAT_DSD By Number of new positives: 50+ 2018 6
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 61,936
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 533
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 346
TB_ART_DSD Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 35
TB_ART_DSD Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 24
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 768
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 463
TB_ART_DSD Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 52
TB_ART_DSD Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 31
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 1,232
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 865
TX_CURR_DSD Age/Sex: 10-14 Female 2018 1,134
TX_CURR_DSD Age/Sex: 10-14 Male 2018 1,274
TX_CURR_DSD Age/Sex: 15-19 Female 2018 5,015
TX_CURR_DSD Age/Sex: 15-19 Male 2018 2,324
TX_CURR_DSD Age/Sex: 20-24 Female 2018 5,897
TX_CURR_DSD Age/Sex: 20-24 Male 2018 3,141
TX_CURR_DSD Age/Sex: 25-49 Female 2018 33,355
TX_CURR_DSD Age/Sex: 25-49 Male 2018 20,798
TX_CURR_DSD Age/Sex: 50+ Female 2018 10,034
TX_CURR_DSD Age/Sex: 50+ Male 2018 5,717
TX_CURR_DSD Age/Sex: <1 2018 568
TX_CURR_DSD Age/Sex: <1-9 2018 4,184
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2018 93,432
TX_CURR_DSD Sum of age/sex disaggregates 2018 7,339
TX_NEW_DSD By Age/Sex: 1-9 2018 676
TX_NEW_DSD By Age/Sex: 10-14 Female 2018 231
TX_NEW_DSD By Age/Sex: 10-14 Male 2018 251
TX_NEW_DSD By Age/Sex: 15-19 Female 2018 895
TX_NEW_DSD By Age/Sex: 15-19 Male 2018 457
TX_NEW_DSD By Age/Sex: 20-24 Female 2018 2,392
TX_NEW_DSD By Age/Sex: 20-24 Male 2018 915
TX_NEW_DSD By Age/Sex: 25-49 Female 2018 9,069
TX_NEW_DSD By Age/Sex: 25-49 Male 2018 6,586
TX_NEW_DSD By Age/Sex: 50+ Female 2018 1,144
TX_NEW_DSD By Age/Sex: 50+ Male 2018 1,090
TX_NEW_DSD By Age/Sex: <1 2018 69
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 23,804
TX_NEW_DSD Sum of Age/Sex disaggregates 2018 23,030
TX_PVLS_DSD 15+, Routine, Unknown Sex 2018 986
TX_PVLS_DSD <15, Routine, Unknown Sex 2018 109
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 34,151
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 34,172
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,471
TX_PVLS_DSD Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 3,511
TX_PVLS_DSD Denominator: Indication: Routine 2018 72,311
TX_PVLS_DSD Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 74,714
TX_PVLS_DSD Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 68,593
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 31,072
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 30,112
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 3,136
TX_PVLS_DSD Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 3,104
TX_PVLS_DSD Numerator: Indication: Routine 2018 68,593
TX_PVLS_DSD Numerator: Preg/BF by Indication: Pregnant Routine 2018 2
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 11,155
TX_RET_DSD Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 10,124
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 11,069
TX_RET_DSD Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 10,119
TX_RET_DSD Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 630
TX_RET_DSD Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 540
TX_RET_DSD Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 629
TX_RET_DSD Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 540
TX_RET_DSD Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 20,908
TX_RET_DSD Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 24,167
TX_TB_DSD Number of ART patients who were started on TB treatment during the reporting period 2018 257
TX_TB_DSD Numerator: By Aggregated Age/Sex: 15+, Female 2018 97
TX_TB_DSD Numerator: By Aggregated Age/Sex: 15+, Male 2018 144
TX_TB_DSD Numerator: By Aggregated Age/Sex: <15, Female 2018 7
TX_TB_DSD Numerator: By Aggregated Age/Sex: <15, Male 2018 10
VMMC_CIRC_DSD By Age: 10-14 2018 4,007
VMMC_CIRC_DSD By Age: 15-19 2018 6,722
VMMC_CIRC_DSD By Age: 20-24 2018 6,722
VMMC_CIRC_DSD By Age: 25-29 2018 6,722
VMMC_CIRC_DSD By Age: 30-49 2018 2,698
VMMC_CIRC_DSD By circumcision technique: Surgical VMMC 2018 25,840
VMMC_CIRC_DSD Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2018 26,872
VMMC_CIRC_DSD Sum of age disaggregates (FY15-Current) 2018 26,871
VMMC_CIRC_DSD Sum of age disaggregates (Prior to FY15) 2018 17,451